First Ascent Biomedical

For patients whose cancer has returned, First Ascent Biomedical provides new ways to fight by combining functional drug testing, genomics, and artificial intelligence to design an individualized treatment plan in a week for each patient. Our technology rapidly grows tumor bulk, more importantly chemo-resistant cells enabling the testing 100s of FDA-approved drugs to measure the cellular response of both cell populations. This is the key dataset for the AI engine, supported by genomics data to identify every cancer weakness and identify which drugs work. To Learn More- Contact us at: info@firstascentbio.com Or go to: www.FirstAscentBio.com

Cancer research,cancer treatment,precision therapy,dna sequencing,rna sequencing,functional defined therapy,phenotype screening,personalized pharmacogenomics,targeted therapy,personalized therapy,artificial intelligence,drug development,biomarker development,biomarker validation,biotechnology,precision medicine,healthcare,personalized medicine,ai,and functional precision medicine

First ascent biomedical operates in the Biotechnology research industry.

First ascent biomedical's revenue is 11m - 100m

First ascent biomedical has 11 - 50 employees.